Skip to main content

This job has expired

You will need to login before you can apply for a job.

R&D Specialist (Cell Therapies, Infectious Disease)

Employer
Regeneron Pharmaceuticals, Inc.
Location
Tarrytown, New York
Start date
Aug 25, 2021

View more

Job Details

We are seeking a R&D Specialist with a strong background in immunology to join the Infectious Disease group. This position will be part of a highly innovative team working on cell-based therapeutics for the treatment of infectious diseases. We are looking for a candidate to help lead in vitro validation and in vivo efficacy of engineered B and T lymphocytes in disease models.

As an R&D Specialist in Infectious Diseases, a typical day may include the following: 

-  Apply experience in immunology knowledge and techniques to support research on cell therapies for infectious disease

-  Help design and implement investigative studies with lead scientist

-  Assist in ex vivo engineering and assessment of primary mouse or human lymphocytes

-  Conduct in vivo efficacy studies in murine models

-  Collaborate with other researchers from diverse functional groups to develop novel therapeutics

-  Analyze and present data at group and department meetings

-  Assist in the authoring of documents for publications


This role may be for you if:


-  You enjoying working in a fast-pace team environment

-  You are enthusiastic about developing new therapeutic technology for treatment of infectious disease

To be considered for this role, you must have lab related experience in Immunology, Oncology, or related field. We are seeking a candidate with a strong background in immunology and research experience in primary human and/or mouse lymphocyte culturing and functional characterization (e.g. ELISpot assays, multiparameter flow cytometry, ELISA assays, etc). Candidate should have proven experience working with mouse models. Experience in molecular biology is highly desirable.

Company

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
 
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Stock Symbol: REGN

Stock Exchange: NASDAQ

FacebookTwitterInstagramYouTube Logo

Company info
Website
Phone
914-847-7000
Location
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert